marketcaparena

Regentis Biomaterials Ltd.

RGNT

About Regentis Biomaterials

regentis.co ↗

Leadership

  • Ehud GellerChief Executive Officer
  • Ori GonChief Financial Officer
  • Galit ReskeChief Medical Officer
  • Arie GordashnikovChief Accounting Officer
Business address
OR AKIVA
Fiscal year ends
December 31
Listed
NYSE · RGNT

Price

Share price

Daily closing price. The header shows the latest close, the market cap at that close and the change over the selected range. Hover or tap the chart to read any day.
$1.70
−$5.80 (−77.33%)since Dec 4, 2025
Market cap
$9M
At close
Oct 8, 2026

Share price vs index

Regentis Biomaterials's share price and the index, each as its percentage change since the first day of the selected range. The shading shows the gap: green while Regentis Biomaterials is ahead, orange while it is behind. The values at the end are each one's change over the range.

Income statement

Revenue, gross profit and net income

FY25
Full year
Revenue, gross profit and net income on one scale, so their sizes can be compared period by period.

Cash flow

Operating and free cash flow

FY25
Full year
Free cash flow is what is left of operating cash flow after capital expenditure. The gap between each pair of bars is that year's capex.

Capital allocation

FY25
Full year
Operating cash flow above zero; what it was spent on below: capital expenditure, dividends and buybacks.

Stock-based compensation

FY25
Full year
Stock-based compensation reported in the cash flow statement each period. The line is that amount as a percentage of the same period's revenue.
Stock-based compensation

Balance sheet

Assets, liabilities and equity

Q4 25
Full year
Quarter
The balance sheet at the end of the chosen year or quarter. What the company owns on the left, against what it owes and what belongs to shareholders on the right. Both columns add up to total assets.